Implementing enclosed sterile integrated robotic platforms to improve cell-based screening for drug discovery
At GSK, we have implemented custom integrated robotics platforms housed in bespoke biosafety enclosures to augment our capabilities in advanced cellular screening.Here we present and discuss the impact of one such system, the Cellular Automated Screening Platform (CASPer).We evaluate the benefits of implementing specific processes microtech 184-10